GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40823)

  • GC81679 structure
    GC81679PLT012
    Purity: >98.50%

    PLT012 is a humanized IgG4 antibody targeting CD36.

  • GC81680 structure
    GC81680Antabactin
    CAS: 2570821-88-2
    Purity: >99.00%

    Antabactin is an ABA receptor antagonist.

  • GC81681 structure
    GC81681Pyroxsulam
    CAS: 422556-08-9
    Purity: >99.00%

    Pyroxsulam is a selective, foliar-applied acetolactate synthase ( ALS )-inhibiting herbicide.

  • GC81682 structure
    GC81682Sialorphin TFA
    Purity: >97.00%

    Sialorphin TFA is a neutral endopeptidase ( NEP ) and aminopeptidase N ( APN ) inhibitor that responds to androgen signals.

  • GC81683 structure
    GC81683AM9053
    CAS: 157469-21-1
    Purity: >98.00%

    AM9053 is a selective, effective and slowly reversible inhibitor of N-acyl ethanolamine acid amidease ( NAAA ) ( IC 50 = 30 nM).

  • GC81684 structure
    GC81684CK37
    CAS: 1001478-90-5
    Purity: >98.00%

    CK37 is a competitive choline kinase-α inhibitor.

  • GC81685 structure
    GC81685GDP-azido-fucose disodium
    CAS: 944560-34-3
    Purity: >99.50%

    GDP-azido-fucose disodium is a glycoengineering tool.

  • GC81686 structure
    GC81686Terbuthylazine-d 9
    CAS: 1346602-52-5
    Purity: >99.00%

    Terbuthylazine -d 9 is the deuterium labeled Terbuthylazine.

  • GC81687 structure
    GC81687cis-V-11-0711
    CAS: 1428338-79-7
    Purity: >98.00%

    cis-V-11-0711 is the cis form of V-11-0711.

  • GC81688 structure
    GC81688GSPT1 degrader-15
    CAS: 3060504-66-4
    Purity: >95.00%

    GSPT1 degrader-15 (Compound Lib-B-15O) is a potent and highly selective GSPT1 molecular gel degrader, with a DC 50 of 154 nM.

  • GC81689 structure
    GC81689Teduglutide-Leu( 13 C 6 , 15 N) sodium
    Purity: >96.50%

    Teduglutide -Leu( 13 C 6, 15 N) (ALX-0600-Leu( 13 C 6, 15 N)) sodium is the 13 C- and 15 N-labeled Teduglutide.

  • GC81690 structure
    GC81690BI1071
    Purity: >98.50%

    BI1071 is an orally active Nur77-Bcl-2 apoptotic pathway modulator.

  • GC81691 structure
    GC81691Nurr1/RXR agonist 1
    CAS: 2231746-53-3
    Purity: >98.00%

    Nurr1/RXR dual agonist 1 is a dual activator of Nurr1 ( EC 50 = 2.6 µM) and RXR with K [1] s of 0.6 and 1.1 µM, respectively.

  • GC81692 structure
    GC81692HY-072808
    CAS: 2230498-45-8
    Purity: >98.50%

    is a cyclic nucleotide phosphodiesterase-4B ( PDE4B ) inhibitor.

  • GC81693 structure
    GC81693GPR52 agonist-4
    CAS: 1313195-88-8
    Purity: >98.00%

    GPR52 agonist-4 (Compound 65) is a highly selective G-protein-coupled receptor GPR52 modulator.

  • GC81695 structure
    GC81695DIM-3,5-Cl2
    CAS: 2595179-74-9
    Purity: >99.00%

    DIM-3,5-Cl2 is an inverse NR4A1/NR4A2 agonist with K D values of 7.7 μM and 12.0 μM for NR4A1 and NR4A2, respectively.

  • GC81696 structure
    GC81696Hepcidin antagonist-1
    CAS: 338965-09-6
    Purity: >98.00%

    Hepcidin antagonist-1 (example 104) is a potent hepcidin (hepcidine) antagonist with an IC 50 <50 μM.

  • GC81697 structure
    GC81697SA91-0178
    CAS: 2244341-81-7
    Purity: >98.00%

    SA91-0178 is a METTL1 inhibitor.

  • GC81698 structure
    GC81698FB231
    CAS: 2166045-37-8
    Purity: >99.00%

    FB231 is a Parkin activator.

  • GC81699 structure
    GC81699(R)-JNJ-40418677 (Standard)
    CAS: 1146594-85-5
    Purity: >98.00%

    (R)-JNJ-40418677 (Standard) is the analytical standard of (R)-JNJ-40418677.

  • GC81700 structure
    GC81700Chloroorienticin A (Standard)
    CAS: 118395-73-6
    Purity: >99.50%

    Chloroorienticin A (Standard) is the analytical standard of Chloroorienticin A.

  • GC81701 structure
    GC81701Polyoxyl 40 stearate (Standard)
    CAS: 171286-89-8
    Purity: >98.00%

    Polyoxyl 40 stearate (Standard) is the analytical standard of Polyoxyl 40 stearate.

  • GC81702 structure
    GC81702GW 590735 (Standard)
    CAS: 343321-96-0
    Purity: >98.00%

    GW 590735 (Standard) is the analytical standard of GW 590735.

  • GC81703 structure
    GC81703NAZ2329 (Standard)
    CAS: 2809469-05-2
    Purity: >98.00%

    NAZ2329 (Standard) is the analytical standard of NAZ2329.